Feb 05
Progestin Injection Policy and Procedure
Clinical policy and procedure for the progestin injection (Depo-Provera).
Blog
Feb 05
Implant Policy and Procedure
Progestin Implant policy and procedure for clinical use.
Feb 04
Medical Eligibility Criteria for Initiating Contraception
A tool for health care providers who want to check a patient’s medical eligibility for various forms of contraception as they relate to absolute and relative contraindications.
Jan 30
IUD Consent Form
A consent form that can be used with patients before inserting an IUD.
Jan 30
Hormonal IUD User Guide
Explains the basics of how to use the progestin intrauterine device (IUD).
Jan 29
Medication Abortion 101
This presentation is designed for those working in primary care settings to introduce medication abortion to staff and help facilitate conversation about providing MAB services at your organization. It covers reproductive justice, the benefits of providing MAB in primary care, common myths about abortion, the basic process of a medication abortion, and more. It is…
Jan 29
How to Order Mifepristone: A Guide for Clinicians and Pharmacies
A step-by-step guide to order mifepristone in the U.S.
Jan 29
Gender-Affirming Reproductive Health in Primary Care
This presentation offers an overview for clinicians who would like to learn more about providing patients with gender-affirming reproductive health care in primary care. Includes a variety of cases to review with learners. If you are interested in CME credit, you can request a workshop. For more information visit our CE webpage.
Jan 28
Insights: The Impacts of Abortion Bans on Maternal Health
Written by Silpa Srinivasulu, MPH After the Dobbs v Jackson Women’s Health decision overturned Roe v. Wade in June 2022, nearly half of US states banned or severely restricted access to abortion care. To date, 12 states ban abortion in nearly all circumstances and six restrict abortion at 12 weeks of pregnancy or less. While…
Jan 21
Possible Drug Interaction Between GLP-1 Agonist and Oral Contraceptives
Written by Sabina Kapkayeva Pharm.D. candidate and Regina Ginzburg, Pharm.D., CDCES, BC-ADM Glucagon-like peptide-1 (GLP-1 agonists) and glucose-dependent insulinotropic peptides (GIP) are increasingly being used in the management of diabetes and/or for weight loss. Several GLP-1 agonist medications available today are known to have interactions with oral hormonal contraceptives, but not through the usual pharmacokinetic…